Sartorius (OTCMKTS:SARTF) Sees Significant Decline in Short Interest

Sartorius (OTCMKTS:SARTF) was the recipient of a large decline in short interest in the month of July. As of July 31st, there was short interest totaling 458 shares, a decline of 49.9% from the July 15th total of 915 shares. Currently, 0.0% of the shares of the company are sold short. Based on an average daily volume of 0 shares, the short-interest ratio is currently ? days.

Sartorius Price Performance

SARTF opened at $212.80 on Friday. Sartorius has a 12 month low of $181.58 and a 12 month high of $227.00. The stock has a market cap of $7.28 billion, a P/E ratio of 98.98 and a beta of 0.98. The stock’s 50 day moving average price is $211.83 and its 200 day moving average price is $218.61. The company has a debt-to-equity ratio of 0.89, a current ratio of 0.95 and a quick ratio of 0.49.

Sartorius Company Profile

Sartorius AG, trading in the U.S. over the counter under the symbol SARTF, is a Germany-based provider of laboratory and bioprocessing equipment for the pharmaceutical, biotechnology and research industries. The company is organized into two core divisions: Bioprocess Solutions, which focuses on single-use consumables, filtration technologies and upstream and downstream processing systems; and Lab Products & Services, which supplies laboratory instruments, consumables and services, including balances, pipettes, cell counting systems and water purification units.

The Bioprocess Solutions segment serves customers engaged in the development and manufacture of biopharmaceuticals, vaccines and advanced therapies.